WebJul 27, 2024 · “RT @CitronResearch: Citron was not going to write just another short report unless we found a co. that we believed was harming the system,…” WebJul 27, 2024 · By Sam Boughedda. Shares of agilon health Inc (NYSE: AGL) fell over 5% Wednesday after Citron Research released a short report with a $5 per share price target. agilon, which currently trades at over $25 per share, down over 2% at the time of writing, is "exploiting short-term loopholes in Medicare /Primary Care," according to Citron.
Citron Research hits Agilon hard - Axios
WebIt is the opinion of Citron Research that agilon health (AGL) is the most vulnerable healthcare stock in the market because they have: • A business model designed for … WebThis is Citron's first such report after founder Andrew Left said last year his company would no longer publish short-selling research, following a bet against videogame retailer GameStop that attracted backlash from retail investors and … tsh repeat
agilon health - AGL Stock Forecast, Price & News
WebDec 5, 2024 · $AGL smoking gun. Not every day does a company publish a definitive statement how they will not achieve profitability as we uncover with agilon. 05 Dec 2024 … WebJul 27, 2024 · -- agilon health shares fell 2% in afternoon trading Wednesday after short-seller Citron Research tagged the company as the most vulnerable health care stock in the market due to its business model... April 5, 2024 WebJul 27, 2024 · Citron was not going to write just another short report unless we found a co. that we believed was harming the system, unprofitable, ridic val to peers, and whose … tsh replacement therapy